There was no significant difference in the expressions of CD117 and MPO, nor in the expression of the early myeloid differentiation marker CD38 between APL and “APL-like” NPM1m AML; both entities likely have their leukemic clones at some stage of differentiation. The gene discussed is MPO; the disease is acute myeloid leukemia.